XPHYF News and Press, XPhyto Therapeutics Corp From 12/08/20

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / December 8, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY) (OTC:XPHYF) (FSE:4XT ) (" XPhyto " or the " Company "), is pleased to announce that it has close...

VANCOUVER, British Columbia, Dec. 08, 2020 (GLOBE NEWSWIRE) -- X P hyto Therapeutics Inc (OTCQB:XPHYF – CSE:XPHY), a next-generation bioscience accelerator based in Vancouver with operations in Germany, today announced that Hugh Rogers, CEO and Director, will pre...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC / ACCESSWIRE / December 3, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto " or the " Company "), is pleased to announce that it has reached...

Psilocybin, mescaline, LSD, MDMA, DMT and other psychedelic compounds added to exclusive dealing agreement for the development of psychedelic-based therapeutics VANCOUVER, BC / ACCESSWIRE / November 10, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto ...

Psilocybin, mescaline, LSD, MDMA, DMT and other psychedelic compounds added to exclusive dealing agreement for the development of psychedelic-based therapeutics VANCOUVER, BC / ACCESSWIRE / November 10, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto ...

Experienced pharma executive and consultant Per S. Thoresen joins board Advisory engagement with CorpCann AS strengthens Europe-focused strategy VANCOUVER, BC / ACCESSWIRE / November 5, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto " or the " C...

Experienced pharma executive and consultant Per S. Thoresen joins board Advisory engagement with CorpCann AS strengthens Europe-focused strategy VANCOUVER, BC / ACCESSWIRE / November 04, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT ) (" XPhyto " or the " Company ...

Research agreement to investigate the feasibility of a proprietary biotechnology process for the industrial production of psilocybin API Psilocybin is designated by the FDA as a breakthrough therapy for severe depression VANCOUVER, BC / ACCESSWIRE / November 03, 2020 / XPhyto T...

25-minute RT-PCR lab test to complement 15-minute rapid test European market launch of both COVID-19 tests planned for Q1 2021 VANCOUVER, BC / ACCESSWIRE / October 28, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY)(OTC:XPHYF)(FSE:4XT ) (" XPhyto " or the " Company "), a next-ge...

VANCOUVER, BC / ACCESSWIRE / October 19, 2020 / XPhyto Therapeutics Corp . ( CSE:XPHY / OTCQB:XPHYF / FSE:4XT ) (" XPhyto " or the " Company "), a next-generation bioscience company, is pleased to announce an update on its third-party contract development programs. Over the past 12 month...